Steven A. Zuniga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Steven A. Zuniga has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Andleeb Khan
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
1 shared publicationDavid M. Souza
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
1 shared publication- Douglas A. Chen
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
1 shared publication - Miriam N. Lango
Department of Head and Neck Surgery MD Anderson Cancer Center Houston Texas USA
1 shared publication Sean Larner
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
1 shared publicationTodd A. Hillman
Pittsburgh Ear Associates, Pittsburgh, Pennsylvania, U.S.A.
1 shared publication
Latest Publications
- 19 September 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (1) , 203-208
Long‐term outcomes of cartilage‐buttressed T‐tube tympanoplasty for prolonged middle ear ventilation
Objectives/Hypothesis: To report on the safety and efficacy of cartilage‐buttressed T‐tube tympanoplasty for long‐term middle ear ventilation, specifically by examining duration of tube survival, as well as adverse events associated with prolonged middle ear intubation, including persistent tympanic membrane perforation.Study Design: Retrospective case series of patients undergoing cartilage‐buttressed T‐tube tympanoplasty between January 2005 and December 2016 in a tertiary‐care neurotology private practice.Methods: Patients who underwent cartilage T‐tube tympanoplasty with complete pre‐ and postoperative audiometric data and a minimum follow‐up duration of 12 months were analyzed. T‐tube survival and adverse events including persistent tympanic membrane perforation were recorded and compared to published data for other long‐term middle ear ventilation techniques.Results: The study cohort included 72 cartilage‐buttressed T‐tube tympanoplasties in 68 patients. Median tube survival was 34 months (range, 2–131 months). Incidence of persistent tympanic membrane perforation (n = 1) was 1.4%Conclusions: Cartilage‐buttressed T‐tube tympanoplasty is a safe and effective means of accomplishing long‐term middle ear ventilation with a considerably lower rate of persistent tympanic membrane perforation as compared to alternative methods of prolonged middle ear ventilation.Level of Evidence: 4 Laryngoscope, 129:203–208, 2019
- 19 September 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (1) , 203-208
Long‐term outcomes of cartilage‐buttressed T‐tube tympanoplasty for prolonged middle ear ventilation
Objectives/Hypothesis: To report on the safety and efficacy of cartilage‐buttressed T‐tube tympanoplasty for long‐term middle ear ventilation, specifically by examining duration of tube survival, as well as adverse events associated with prolonged middle ear intubation, including persistent tympanic membrane perforation.Study Design: Retrospective case series of patients undergoing cartilage‐buttressed T‐tube tympanoplasty between January 2005 and December 2016 in a tertiary‐care neurotology private practice.Methods: Patients who underwent cartilage T‐tube tympanoplasty with complete pre‐ and postoperative audiometric data and a minimum follow‐up duration of 12 months were analyzed. T‐tube survival and adverse events including persistent tympanic membrane perforation were recorded and compared to published data for other long‐term middle ear ventilation techniques.Results: The study cohort included 72 cartilage‐buttressed T‐tube tympanoplasties in 68 patients. Median tube survival was 34 months (range, 2–131 months). Incidence of persistent tympanic membrane perforation (n = 1) was 1.4%Conclusions: Cartilage‐buttressed T‐tube tympanoplasty is a safe and effective means of accomplishing long‐term middle ear ventilation with a considerably lower rate of persistent tympanic membrane perforation as compared to alternative methods of prolonged middle ear ventilation.Level of Evidence: 4 Laryngoscope, 129:203–208, 2019
- 14 December 2017
- Published by Wiley in The Laryngoscope
- Vol. 128 (8) , 1874-1880
Effect of rural and urban geography on larynx cancer incidence and survival
Objectives/Hypothesis: Investigate the impact of rural geography on larynx cancer incidence and survival.Study Design: Surveillance, Epidemiology, and End Results (SEER) database study.Methods: Incidence and survival rates by Rural–Urban Continuum codes for larynx squamous cell carcinoma patients diagnosed from 2004 to 2012 were evaluated using SEER statistical software and Cox proportional hazards survival analysis.Results: The lowest age‐adjusted incidence rates for larynx cancer were seen in densely populated urban regions, with mean rates of 2.8 per 100,000 person years (95% confidence interval [CI]: 2.7‐2.8); the highest were in the most rural areas, with mean rates of 5.3 per 100,000 person years (95% CI: 4.7‐5.9). Nevertheless, of 23,659 larynx cancer patients diagnosed over this period, 19,556 (82.7%) arose in urban residents, compared with 1,428 or 6% from rural areas. Urban larynx cancer patients more likely lived in counties with an American College of Surgeons–approved cancer center and/or a fourfold greater otolaryngology physician supply. Nevertheless, frequency of advanced stage at initial presentation was similar. Cause‐specific and overall survival were no different, both on univariable and multivariable analyses.Conclusions: Compared with urban populations, Rural populations are at greater risk of developing larynx cancer, but initial stage and survival after diagnosis are comparable. Priority should be given to prevention strategies to decrease incidence rates.Level of Evidence: 4 Laryngoscope, 1874–1880, 2018
- 14 December 2017
- Published by Wiley in The Laryngoscope
- Vol. 128 (8) , 1874-1880
Effect of rural and urban geography on larynx cancer incidence and survival
Objectives/Hypothesis: Investigate the impact of rural geography on larynx cancer incidence and survival.Study Design: Surveillance, Epidemiology, and End Results (SEER) database study.Methods: Incidence and survival rates by Rural–Urban Continuum codes for larynx squamous cell carcinoma patients diagnosed from 2004 to 2012 were evaluated using SEER statistical software and Cox proportional hazards survival analysis.Results: The lowest age‐adjusted incidence rates for larynx cancer were seen in densely populated urban regions, with mean rates of 2.8 per 100,000 person years (95% confidence interval [CI]: 2.7‐2.8); the highest were in the most rural areas, with mean rates of 5.3 per 100,000 person years (95% CI: 4.7‐5.9). Nevertheless, of 23,659 larynx cancer patients diagnosed over this period, 19,556 (82.7%) arose in urban residents, compared with 1,428 or 6% from rural areas. Urban larynx cancer patients more likely lived in counties with an American College of Surgeons–approved cancer center and/or a fourfold greater otolaryngology physician supply. Nevertheless, frequency of advanced stage at initial presentation was similar. Cause‐specific and overall survival were no different, both on univariable and multivariable analyses.Conclusions: Compared with urban populations, Rural populations are at greater risk of developing larynx cancer, but initial stage and survival after diagnosis are comparable. Priority should be given to prevention strategies to decrease incidence rates.Level of Evidence: 4 Laryngoscope, 1874–1880, 2018